Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|
All Comparisons

Cerebrolysin vs Cortagen

Research material comparison: purity standards, available formats, molecular data, batch COA documentation, and regulatory status. For in vitro research use only.

Cerebrolysin: CCortagen: D
AttributeCerebrolysinCortagen
CategoryNootropic / NeuroprotectiveNootropic / Neuroprotective
Evidence RatingCPhase I–II Clinical TrialsDPreclinical / Uncontrolled Russian Studies
Clinical StatusApproved as prescription drug in 50+ countries (Austria, Russia, China, South Korea, and others). Not FDA-approved. Over 150 clinical trials with >7,000 patients.Preclinical / small open-label Russian studies only. No controlled clinical trials. Available as a dietary supplement in Russia.
MechanismCerebrolysin provides multimodal neuroprotection through several pathways: it enhances neurogenesis and neuroplasticity via activation of PI3K/AKT and Sonic Hedgehog (Shh) signaling, promotes synaptic remodeling through CREB phosphorylation and BDNF-like activity, inhibits calpain-mediated neuronal ...Cortagen is proposed by the Khavinson group to penetrate cells and interact with DNA regulatory sequences to normalize gene expression in cortical neurons. Preclinical studies from the developer report that cortagen promotes neuronal survival under ischemic and neurotoxic conditions, modulates neuro...
Half-Life
Bioavailability
Molecular Weight~446 g/mol
WADA StatusNot ListedNot Listed
Research Half-Life
Key Use Cases
  • Cognitive Enhancement
  • Neuroprotection Research
  • Anti-Aging Research
Safety Concerns
  • Generally well-tolerated in clinical trials
  • Common: dizziness, headache, injection site reactions
  • Rare: agitation, fever, flu-like symptoms
  • No controlled safety studies have been conducted
  • No serious adverse effects reported in Russian open-label observations
  • Long-term safety is unknown
Contraindications
  • Epilepsy or history of seizures
  • Severe renal impairment
  • Known allergy to porcine-derived products
  • Pregnancy and breastfeeding
  • Pregnancy and breastfeeding (no safety data)
  • No established contraindications due to absence of clinical data
  • Not recommended as a substitute for evidence-based neurological treatments
Regulatory (US)Not FDA-approved. No IND application. Cannot be legally prescribed.Not FDA-approved or evaluated. Occasionally sold online as a research peptide.

Research Material Specifications

Catalog specifications for the corresponding research materials, including batch documentation coverage.

SpecificationCerebrolysinCortagen
Purity Standard≥98%≥98%
CAS NumberN/AN/A
Molecular FormulaN/AN/A
Available Formats60mg20mg
Batch COAs Published
Stock StatusOut of stockOut of stock

Research Disclaimer: This comparison is provided for educational purposes only. All products are sold exclusively for in vitro research use. The information presented is based on published preclinical and clinical research and does not constitute medical advice. Consult a qualified healthcare professional before making any decisions regarding peptide use.

Explore More
Comparisons

Compare any two peptides side-by-side or browse our curated popular matchups.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.